Onco Drug Personalized Medicine

Tweet this page
<
2019
2020
2021
2022
>
No longer registered as of 15 Mar 2023 - Registration as it was on 13 May 2022
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

50,000€ - 99,999€

Financial year: Jan 2021 - Dec 2021

Lobbyists (Full time equivalent)

0.5 Fte (2)

Lobbyists with EP accreditation

0

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    Onco Drug Personalized Medicine   (ODPM)

    EU Transparency Register

    664759134647-66 First registered on 24 Apr 2019

    Goals / Remit

    Créée en 2010, ODPM développe et commercialise des solutions permettant une réelle individualisation thérapeutique en cancérologie. Ses offres ont été élaborées à l'issue des travaux de recherche du laboratoire d'oncopharmacologie de l’Institut de Cancérologie de l’Ouest (ICO) site Paul Papin à Angers et de l'Université d'Angers.

    Main EU files targeted

    Cancérologie, sécurité des patients, médicaments à usage humain, value-based healthcare, Horizon Europe

    Address

    Head Office
    2 rue Ignace Dubus Bonnel
    Saint Leger De Linières 49170
    FRANCE
    EU Office
    2 rue Ignace Dubus Bonnel
    St Leger de Linières 49170 - 49170
    FRANCE

    Website

  • People

    Total lobbyists declared

    2

    Employment timeLobbyists
    25%2

    Lobbyists (Full time equivalent)

    0.5

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Companies & groups

  • Networking

    Affiliation

    SIDIV (www.sidiv.fr)
    Atlanpole Biothérapies (www.atlanpolebiotherapies.com)

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2021 - Dec 2021

    Lobbying costs for closed financial year

    50,000€ - 99,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    None declared

    Intermediaries for current year

    None declared

    Closed year Costs

    50,000€ - 99,999€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Communication activities

    None

    Other activities

    None declared

  • Meetings

    Meetings

    None declared

Download this datacard